Rotablation in Patients with Advanced Renal Insufficiency through End-Stage Renal Disease: Short- and Intermediate-Term Results

Table 3

Incidence of in-procedural complications and acute contrast-induced nephropathy in patients with CR < 5 mg/dl and CR ≥ 5 mg/dl through ESRD.

Variables	Group A	Group B	value
	(CR < 5 mg/dl through ESRD)	(CR >= 5 mg/dl through ESRD)
	N = 338	N = 73
Acute slow/no flow (N, %)	31 (9.2%)	4 (5.5%)	0.305
Wire transection (N, %)	1 (0.3%)	0	—
Vessel perforation (N, %)	4 (1.2%)	1 (1.4%)	0.895
Acute heart failure (N, %)	13 (3.8%)	1 (1.4%)	0.290
Profound/refractory shock	47 (13.9%)	3 (4.1%)	0.020
Ventricular arrhythmia (N, %)	7 (2.1%)	2 (2.7%)	0.723
Emergent CABG (N, %)	0	0	—
Die on table (N, %)	0	0	—
Acute CIN (N, %)	17 (5.0%)	4 (5.5%)	0.863
Access hematoma (N, %)	10 (3.0%)	0	0.136
IIb/IIIa inhibitors (N, %)	8 (2.4%)	1 (1.4%)	0.594

CABG, coronary artery bypass grafting; CIN, contrast-induced nephropathy; CR, creatinine; ESRD, end-stage renal disease. Excluding patients on regular hemodialysis.